M. Mamas

First name
M.
Middle name
A.
Last name
Mamas
Pate, A., Sperrin, M., Riley, R. D., Sergeant, J. C., Van Staa, T., Peek, N., et al. (2023). Developing prediction models to estimate the risk of two survival outcomes both occurring: A comparison of techniques. Stat Med. http://doi.org/10.1002/sim.9771
Jordan, K. P., Rathod-Mistry, T., van der Windt, D. A., Bailey, J., Chen, Y., Clarson, L., et al. (2023). Determining cardiovascular risk in patients with unattributed chest pain in UK primary care: an electronic health record study. Eur J Prev Cardiol. http://doi.org/10.1093/eurjpc/zwad055
Cipolletta, E., Tata, L. J., Nakafero, G., Avery, A. J., Mamas, M. A., & Abhishek, A. (2023). Risk of venous thromboembolism with gout flares. Arthritis Rheumatol. http://doi.org/10.1002/art.42480
Mason, K. J., Jordan, K. P., Heron, N., Edwards, J. J., Bailey, J., Achana, F. A., et al. Musculoskeletal pain and its impact on prognosis following acute coronary syndrome or stroke: A linked electronic health record cohort study. Musculoskeletal Care, 1– 14. http://doi.org/https://doi.org/10.1002/msc.1748
. Y. Sun, L., Zghebi, S. S., Eddeen, A. B., Liu, P. P., Lee, D. S., Tu, K., et al. (2022). Derivation and External Validation of a Clinical Model to Predict Heart Failure Onset in Patients With Incident Diabetes. Diabetes Care, 45, 2737-2745. http://doi.org/10.2337/dc22-0894
Cipolletta, E., Tata, L. J., Nakafero, G., Avery, A. J., Mamas, M. A., & Abhishek, A. (2022). Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout. Jama, 328, 440-450. http://doi.org/10.1001/jama.2022.11390
Wu, J., Nadarajah, R., Nakao, Y. M., Nakao, K., Wilkinson, C., Mamas, M. A., et al. (2022). Temporal trends and patterns in atrial fibrillation incidence: A population-based study of 3·4 million individuals. Lancet Reg Health Eur, 17, 100386. http://doi.org/10.1016/j.lanepe.2022.100386
Ajabnoor, A. M., Zghebi, S. S., Parisi, R., Ashcroft, D. M., Rutter, M. K., Doran, T., et al. (2022). Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study. Plos Med, 19, e1004003. http://doi.org/10.1371/journal.pmed.1004003
Jordan, K. P., Rathod-Mistry, T., Bailey, J., Chen, Y., Clarson, L., Denaxas, S., et al. (2022). Long-Term Cardiovascular Risk and Management of Patients Recorded in Primary Care With Unattributed Chest Pain: An Electronic Health Record Study. J Am Heart Assoc, 11, e023146. http://doi.org/10.1161/jaha.121.023146
Wright, A. K., Carr, M. J., Kontopantelis, E., Leelarathna, L., Thabit, H., Emsley, R., et al. (2022). Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc21-1113